Researchers at the 4th annual International AIDS Society meeting have been discussing plans for a new study that will determine if early treatment — starting patients on antiretrovirals when their CD4 counts hit the 500 level, as opposed to waiting for the current warning level of 200 or lower — might help HIV positive patients lower their risk of developing diseases that aren’t typically associated with HIV. Recent studies have supported earlier treatment by showing that even in the so-called “latency” period soon after a person is diagnosed with HIV, they might be at an increased risk for various “non-AIDS related” illnesses.
SugarandSpice43
